CAPITAL STOCK AND ADDITIONAL PAID-IN CAPITAL | NOTE 6 – CAPITAL STOCK AND ADDITIONAL PAID-IN CAPITAL The Company has authorized 600,000,000 shares of common stock, with a par value of $0.0001 per share. There were no shares issued during the three months ended June 30, 2023. During the three months ended March 31, 2023, the Company received proceeds of $250,000 from an investor in the form of a subscription under our current offering at $0.12 per unit for a total of 2,083,333 common shares and 520,822 common stock purchase warrants for exercise at $0.15 per share with an exercise term of one (1) year from issue date. During the year ended December 31, 2022, the Company issued a total of 13,714,547 shares of common stock as loan bonus’ to Noteholders in conjunction with the terms of certain loan agreements. (Ref: Note 5 – Debt). On June 30, 2023, and December 31, 2022, the Company had 273,718,580 and 271,635,247 shares of common stock issued and outstanding, respectively. Stock Purchase Warrants During the year ended December 31, 2022, the Company issued a total of 1,958,333 stock purchase warrants with respect to certain short term promissory notes payable for a period of one (1) year from grant date with an exercise price of $0.12 per share. The fair value of the warrants was $165,602, which amount was recorded as financing costs. Concurrent with the issuance of the New Notes, a total of 291,667 warrants issued to a company controlled by our CEO in June 2022 were cancelled. Warrant transactions are summarized as follows: Number of Warrants Weighted Average Exercise Price ($) Balance, December 31, 2021 20,331,658 0.07 Warrants issued 1,958,333 0.12 Warrants cancelled (291,667 ) 0.12 Warrants expired - - Balance, December 31, 2022 21,998,324 $ 0.074 Warrants issued 520,822 0.15 Warrants cancelled - - Warrants expired (1,666,666 ) 0.12 Balance, June 30, 2023 20,852,480 $ 0.072 The following warrants were outstanding as at June 30, 2023: Number of Warrants Exercise Price ($) Expiry Date 1,333,333 0.0975 September 09, 2023 500,000 0.0975 September 27, 2023 7,791,658 0.02567 October 1, 2023 333,333 0.0975 October 18, 2023 5,666,667 0.0975 October 19, 2023 1,000,000 0.0975 October 21, 2023 240,000 0.0975 October 24, 2023 666,667 0.0975 October 26, 2023 666,667 0.0975 October 28, 2023 600,000 0.0975 October 29, 2023 800,000 0.0975 November 01, 2023 533,333 0.0975 November 02, 2023 200,000 0.0975 November 19, 2023 520,822 0.15 January 24, 2024 20,852,480 Stock Options The Company granted the following stock options under its 2021 Employee Stock Incentive Plan: - On October 1, 2021, 9,000,000 fully vested incentive stock options were granted to directors, officers and consultants of the Company for exercise at $0.0257 for a term of 4 years from grant - On October 26, 2021, 7,077,422 qualified employee stock options were granted to certain officers, directors and employees of the Company’s wholly owned subsidiary, Stratford Ltd, for exercise at $0.123 per share for a period of four years from grant and vesting as to 25% on the first anniversary of the Vesting Commencement Date (the “Cliff Date”), with an additional 6.25% of the option vesting at the end of each three (3) month period following the Cliff Date. The options shall become fully vested by the fourth anniversary of the vesting commencement date of October 26, 2021. - On November 11, 2021, 11,465,424 qualified employee stock options were granted to certain officers and employees of the Company’s wholly owned subsidiary, Stratford Ltd, for exercise at $0.02567 per share for a period of four years from grant and vesting as to 25% on the first anniversary of the Cliff Date with an additional 6.25% of the option vesting at the end of each three (3) month period following the Cliff Date. The options shall become fully vested by the fourth anniversary of the vesting commencement date of May 2, 2021. - On June 13, 2022, 1,500,414 qualified employee stock options were granted to certain officers and employees of the Company’s wholly owned subsidiary, Stratford Ltd, for exercise at $0.103 per share for a period of five years from grant and vesting as to 25% on the first anniversary of the Cliff Date, with an additional 6.25% of the option vesting at the end of each three (3) month period following the Cliff Date. The options shall become fully vested by the fourth anniversary of the vesting commencement dates between November 2021 and June 2022. - On August 1, 2022, 1,833,334 qualified employee stock options were granted to certain officers and employees of the Company’s wholly owned subsidiary, Stratford Ltd for exercise at $0.0781 per share for a period of five years from grant and vesting as to 25% on the first anniversary of the Cliff Date, with an additional 6.25% of the option vesting at the end of each three (3) month period following the Cliff Date. The options shall become fully vested by the fourth anniversary of the vesting commencement date in August 2022. - During the year ended December 31, 2022, a total of 8,670,584 employee stock options were canceled and a further 636,969 forfeit upon termination of service agreements. - On January 6, 2023, 6,883,097 qualified employee stock options were granted to certain officers and employees of the Company’s wholly owned subsidiary, Stratford Ltd, for exercise at $0.0797 per share for a period of five years from grant and vesting as to 25% on the first anniversary of the Cliff Date, with an additional 6.25% of the option vesting at the end of each three (3) month period following the Cliff Date. The Options shall become fully vested by the fourth anniversary of the vesting commencement dates between September 2022 and December 2022. - On January 6, 2023, 3,000,000 fully vested incentive stock options were granted to directors and officers of the Company for exercise at $0.0797 for a term of 5 years from grant - During the three months ended March 31, 2023, 2,000,000 unvested options were forfeit upon termination of an employment agreement (March 31, 2022 – Nil). - During the three months ended June 30, 2023, the Company granted 2,000,000 qualified stock options to an employee and 14,830,580 unvested options were forfeit upon termination of certain employment agreements and the release of certain Stratford employees due to an insolvency proceeding commenced in June 2023 (June 30, 2022– 1,415,484). Additional information with respect to the stock option activity is as follows: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Term in Years Aggregate Intrinsic Value Outstanding at December 31, 2022 21,569,040 $ 0.03508 2.77 $ - Granted 11,883,097 0.0797 5 - Exercised - - - - Cancelled - - Forfeiture (16,830,580 ) 0.06284 - - Outstanding at June 30, 2023 16,621,557 $ 0.047 2.56 $ - Options exercisable at June 30, 2023 16,621,557 $ 0.03636 2.56 $ - Number of Shares Weighted Average Exercise Price Weighted Average Remaining Term in Years Aggregate Intrinsic Value Outstanding at December 31, 2021 27,542,845 $ 0.05068 3.60 $ - Granted - - - - Exercised - - - - Cancelled - - - - Forfeiture - - - - Outstanding at June 30, 2022 27,542,845 $ 0.05068 3.10 $ - Options exercisable at June 30, 2022 9,000,000 $ 0.02567 3.25 $ - The following table summarizes information about stock options outstanding and exercisable at June 30, 2023: Range of Exercise Prices Number of Shares Outstanding Weighted Average Remaining in Contractual Life in Years Outstanding Options Weighted Average Exercise Price Number of Options Exercisable Exercisable Options Weighted Average Exercise Price $ 0.02567 9,000,000 2.26 $ 0.02567 9,000,000 $ 0.02567 $ 0.02567 4,458,776 1.84 $ 0.02567 4,458,776 $ 0.02567 $ 0.12300 141,548 2.33 $ 0.12300 141,548 $ 0.12300 $ 0.10300 21,233 3.96 $ 0.10300 21,233 $ 0.10300 $ 0.07977 3,000,000 4.52 $ 0.07977 3,000,000 $ 0.007977 $0.02567 ~ $0.12300 16,621,557 2.56 $ 0.02567 16,621,557 $ 0.02567 The following table summarizes information about stock options outstanding and exercisable at June 30, 2022: Range of Exercise Prices Number of Shares Outstanding Weighted Average Remaining in Contractual Life in Years Outstanding Options Weighted Average Exercise Price Number of Options Exercisable Exercisable Options Weighted Average Exercise Price $ 0.02567 9,000,000 3.25 $ 0.02567 9,000,000 $ 0.02567 $ 0.02567 11,465,423 2.84 $ 0.02567 - $ - $ 0.12300 5,661,938 3.32 $ 0.12300 - $ - $ 0.10300 1,500,414 4.92 $ 0.10300 - $ - $0.02567 ~ 0.12300 27,542,845 3.18 $ 0.05068 9,000,000 $ 0.02567 Unamortized compensation expense associated with unvested options is $0 and $183,380 as of June 30, 2023 and December 31, 2022, respectively. The weighted average period over which these costs are expected to be recognized is approximately 0 years. |